ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2012;94:241-246. doi:10.1016/j.athoracsur.2012.03.062
© 2012 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Giuseppe Cardillo
Federico Rea
Marco Lucchi
Marinus A. Paul
Stefano Margaritora
Francesco Carleo
Giuseppe Marulli
Alfredo Mussi
Pierluigi Granone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cardillo, G.
Right arrow Articles by Graziano, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardillo, G.
Right arrow Articles by Graziano, P.
Related Collections
Right arrow Mediastinum


Original Articles: General Thoracic

Primary Neuroendocrine Tumors of the Thymus: A Multicenter Experience of 35 Patients

Giuseppe Cardillo, FRCS, FETCSa,*, Federico Rea, MDb, Marco Lucchi, MDc, Marinus A. Paul, MDd, Stefano Margaritora, MDe,f, Francesco Carleo, MDa, Giuseppe Marulli, MDb, Alfredo Mussi, MDc, Pierluigi Granone, MDe, Paolo Graziano, MDg

a Department of Thoracic Surgery, Azienda Ospedaliera San Camillo Forlanini, Carlo Forlanini Hospital, Rome, Italy
b Department of Thoracic Surgery, University of Padua, Padua, Italy
c Department of Thoracic Surgery, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
d Department of Thoracic Surgery, VU University Medical Center, Amsterdam, the Netherlands
e Department of Thoracic Surgery, Catholic University of Sacred Heart, Rome, Italy
f Department of Thoracic Surgery, Centro Oncologico Fiorentino, Florence, Italy
g Unit of Pathology, Azienda Ospedaliera San Camillo Forlanini, Carlo Forlanini Hospital, Rome, Italy

Accepted for publication March 22, 2012.

* Address correspondence to Mr Cardillo, Unit of Thoracic Surgery, Carlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome 00149, Italy (Email: gcardillo{at}scamilloforlanini.rm.it).

Presented at the Forty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–Feb 1, 2012.

Background: Primary neuroendocrine tumors of the thymus (NETT) are rare tumors and represent a distinct category of tumors collectively displaying morphologic and biological neuroendocrine features. We sought to evaluate factors influencing long-term survival in patients with primary NETT.

Methods: From January 1990 to April 2011, 35 patients (27 male patients and 8 female patients) were surgically treated for primary NETT at 5 institutions.

Results: No operative (30-day) mortality occurred. Morbidity was 37.14% (13/35 patients). All patients were followed for a total of 2,703 months. Fourteen patients had associated paraneoplastic syndrome. Twenty-four patients are alive, 19 of whom are free of disease and 5 of whom continue to have disease. The median overall survival was 153 months. The overall 5-year and 10-year actuarial survival rates were 84.34% and 60.82%, respectively. The 10-year survival was evaluated according to histologic type (typical carcinoid, 77.92%; atypical carcinoid, 54.55%; large-cell neuroendocrine carcinomas, 0%; Masaoka staging (stage I, 100%; stage II, 66.67%; stage III, 61.9%; stage Iva, 25%; stage IVb, 0%), presence of paraneoplastic syndrome (no = 70.67%; yes = 32.14%), postoperative radiotherapy (yes = 39.71%; no = 85.71.%), Surveillance, Epidemiology, and End Results (SEER) staging system (localized disease, 83.3%; regional disease, 53.3%; distant disease, 0%), tumor size (<7 cm = 90.9%; ≥7cm = 28.7%; p = 0.0007), and Ki67 expression, which was available in 23 patients (<10% = 85.71%; ≥10% = 0%; p = 0.0037).

Conclusions: The prognosis of primary NETT is statistically significantly related to tumor size >7 cm and to the proliferation index (evaluated by Ki67 expression >10%). The histologic type of the neoplasm, the presence of a paraneoplastic syndrome, the Masaoka staging, the evidence of distant disease, and postoperative radiotherapy also impact prognosis.




This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
Y. Zhou, C. Chen, M. Bao, G. Jiang, and Y. Zhu
Preoperative embolization followed by surgical excision of a giant thymic carcinoid
Interact CardioVasc Thorac Surg, April 1, 2013; 16(4): 541 - 543.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2012 by The Society of Thoracic Surgeons.